Patents by Inventor Samarth Kumar

Samarth Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11241379
    Abstract: The present invention relates to a parenteral dosage form comprising a) a ready-to-infuse, stable aqueous solution comprising diltiazem or its pharmaceutically acceptable salt, pH adjusting agent to provide a pH in the range of 3 to 5 and ethanol, and b) an infusion container filled with said aqueous solution.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: February 8, 2022
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Samarth Kumar, Milan Natvarbhai Thakkar, Kandarp Maheshkumar Dave
  • Publication number: 20220000776
    Abstract: The present invention provides a parenteral dosage form consisting essentially of a solution filled in a container, the solution comprising amiodarone or its pharmaceutically acceptable salt and a sulfo-alkyl ether beta-cyclodextrin in an aqueous vehicle, wherein the solution has a pH in the range of about 2.4 to 3.9 and further wherein the dosage form is sterilized by subjecting the filled container to autoclaving.
    Type: Application
    Filed: September 15, 2021
    Publication date: January 6, 2022
    Inventors: Samarth Kumar, Soni Maheshkumar Parasmal, Milan Mohanbhai Vasoya, Prashant Kane, Subhas Balaram Bhowmick, Rajamannar Thennati
  • Publication number: 20210401669
    Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 4, 2020
    Publication date: December 30, 2021
    Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Nishit PATEL, Prashant KANE, Subhas Balaram BHOWMICK
  • Patent number: 11197838
    Abstract: The present invention provides a ready to use stable aqueous dosage form of norepinephrine comprising an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, one or more sulfite antioxidants and an ion chelator. The present invention also provides an infusion container filled with an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, wherein the said solution is stable for a prolonged period of time and can be terminally sterilized by autoclaving.
    Type: Grant
    Filed: August 10, 2020
    Date of Patent: December 14, 2021
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Samarth Kumar, Maheshkumar Parasmal Soni, Praveen Kumar Srivastava, Prashant Kane, Subhas Balaram Bhowmick
  • Publication number: 20210369565
    Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof.
    Type: Application
    Filed: February 20, 2020
    Publication date: December 2, 2021
    Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Nishit PATEL, Prashant KANE, Subhas Balaram BHOWMICK
  • Patent number: 11166911
    Abstract: The present invention provides a parenteral dosage form consisting essentially of a solution filled in a container, the solution comprising amiodarone or its pharmaceutically acceptable salt and a sulfo-alkyl ether beta-cyclodextrin in an aqueous vehicle, wherein the solution has a pH in the range of about 2.4 to 3.9 and further wherein the dosage form is sterilized by subjecting the filled container to autoclaving.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: November 9, 2021
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Samarth Kumar, Soni Maheshkumar Parasmal, Milan Mohanbhai Vasoya, Prashant Kane, Subhas Balaram Bhowmick, Rajamannar Thennati
  • Patent number: 11166923
    Abstract: The present invention relates to a ready-to-administer parenteral dosage form of norepinephrine which comprises an aqueous solution of norepinephrine, having an anti-oxidant which is not a sulfite anti-oxidant, wherein the dosage form is stable at room temperature for prolonged period of time.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: November 9, 2021
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Rakesh Thummar, Shantaram Pawar, Prashant Kane, Subhas Balaram Bhowmick, Samarth Kumar, Milan Natvarbhai Thakkar, Kandarp Maheshkumar Dave
  • Publication number: 20210308118
    Abstract: The present invention relates to a dosage form comprising an aqueous solution of a vinca alkaloid drug or its pharmaceutically acceptable salt in a flexible infusion container, and a light protective secondary packaging containing the flexible infusion container, wherein the dosage form is ready-to-infuse and wherein the aqueous solution is stable at room temperature.
    Type: Application
    Filed: June 17, 2021
    Publication date: October 7, 2021
    Inventors: Subhas Balaram Bhowmick, Prashant Kane, Samarth Kumar, Ramaji Karshanbhai Varu, Nisarg Bipinchandra Mistry, Swapnil Ramesh Patil
  • Patent number: 11058679
    Abstract: The present invention relates to a dosage form comprising an aqueous solution of a vinca alkaloid drug or its pharmaceutically acceptable salt in a flexible infusion container, and a light protective secondary packaging containing the flexible infusion container, wherein the dosage form is ready-to-infuse and wherein the aqueous solution is stable at room temperature.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: July 13, 2021
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Subhas Balaram Bhowmick, Prashant Kane, Samarth Kumar, Ramaji Karshanbhai Varu, Nisarg Bipinchandra Mistry, Swapnil Ramesh Patil
  • Publication number: 20210128562
    Abstract: The present invention refers to an intravenous infusion dosage form comprising a composition containing pemetrexed or its pharmaceutically acceptable salt, an osmagent and an aquous vehicle. The composition is present in a flexible infusion container containing an inert gas in the headspace. Additionally, a second container may be present surrounding the flexible infusion container.
    Type: Application
    Filed: November 19, 2020
    Publication date: May 6, 2021
    Applicant: Sun Pharmaceutical Industries Limited
    Inventors: Samarth Kumar, Prashant Kane, Subhas Balaram Bhowmick, Kirti Ganorkar, Nisarg Bipinchandra Mistry, Ramaji Karshanbhai Varu
  • Publication number: 20210100947
    Abstract: A perfusion container for directly administering to patients a dose of an antineoplastic drug calculated according to a patient's parameter, wherein the first perfusion container comprises a solution of antineoplastic drug at a concentration and volume such that the amount of antineoplastic drug in the container is equal to the calculated dose for one patient but less than the calculated dose for a second patient, the calculated dose is provided to first patient within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container, further the first perfusion container is accompanied by a second top-up perfusion container comprising a solution of antineoplastic drug at a concentration and volume such that the calculated dose is provided within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container and the second top-up container to the second patient.
    Type: Application
    Filed: December 18, 2020
    Publication date: April 8, 2021
    Applicant: Sun Pharmaceutical Industries Limited
    Inventors: Subhas Balaram BHOWMICK, Prashant Kane, Samarth KUMAR, Kirti Ganorkar
  • Publication number: 20210038539
    Abstract: The present invention provides a ready to use stable aqueous dosage form of norepinephrine comprising an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, one or more sulfite antioxidants and an ion chelator. The present invention also provides an infusion container filled with an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, wherein the said solution is stable for a prolonged period of time and can be terminally sterilized by autoclaving.
    Type: Application
    Filed: August 10, 2020
    Publication date: February 11, 2021
    Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Praveen Kumar SRIVASTAVA, Prashant KANE, Subhas Balaram BHOWMICK
  • Patent number: 10869867
    Abstract: The present invention relates to an intravenous infusion dosage form of pemetrexed or its pharmaceutically acceptable salt, having long term stability.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: December 22, 2020
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Samarth Kumar, Prashant Kane, Subhas Balaram Bhowmick, Kirti Ganorkar, Nisarg Bipinchandra Mistry, Ramaji Karshanbhai Varu
  • Publication number: 20200360598
    Abstract: A perfusion container for directly administering to patients a dose of an antineoplastic drug calculated according to a patient's parameter, wherein the first perfusion container comprises a solution of antineoplastic drug at a concentration and volume such that the amount of antineoplastic drug in the container is equal to the calculated dose for one patient but less than the calculated dose for a second patient, the calculated dose is provided to first patient within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container, further the first perfusion container is accompanied by a second top-up perfusion container comprising a solution of antineoplastic drug at a concentration and volume such that the calculated dose is provided within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container and the second top-up container to the second patient.
    Type: Application
    Filed: February 9, 2017
    Publication date: November 19, 2020
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Subhas Balaram BHOWMICK, Prashant KANE, Samarth KUMAR, Kirti GANORKAR
  • Publication number: 20200315913
    Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 4, 2020
    Publication date: October 8, 2020
    Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Nishit PATEL, Prashant KANE, Subhas Balaram BHOWMICK
  • Publication number: 20200268606
    Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof.
    Type: Application
    Filed: February 20, 2020
    Publication date: August 27, 2020
    Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Nishit PATEL, Prashant KANE, Subhas Balaram BHOWMICK
  • Publication number: 20200246254
    Abstract: The present invention relates to a parenteral dosage form comprising a) a ready-to-infuse, stable aqueous solution comprising diltiazem or its pharmaceutically acceptable salt, pH adjusting agent to provide a pH in the range of 3 to 5 and ethanol, and b) an infusion container filled with said aqueous solution.
    Type: Application
    Filed: December 1, 2016
    Publication date: August 6, 2020
    Inventors: Samarth KUMAR, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
  • Patent number: D905788
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: December 22, 2020
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Samarth Kumar, Prashant Kane, Mark Hagler, Kartik Nagar, Sapna Fadnis, Raman Lad, Subhas Balaram Bhowmick
  • Patent number: D908869
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: January 26, 2021
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Samarth Kumar, Prashant Kane, Mark Hagler, Kartik Nagar, Sapna Fadnis, Raman Lad, Subhas Balaram Bhowmick
  • Patent number: D925355
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: July 20, 2021
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Samarth Kumar, Prashant Kane, Mark Hagler, Kartik Nagar, Sapna Fadnis, Raman Lad, Subhas Balaram Bhowmick